PATHOGENESIS OF POSTTRANSPLANT HYPERLIPIDEMIA

移植后高脂血症的发病机制

• 批准号: 6244330
• 负责人: BRADLEY J MARONI
• 金额: $ 3.62万
• 依托单位: EMORY UNIVERSITY
• 依托单位国家: 美国
• 财政年份: 1997
• 资助国家: 美国
• 起止时间: 1997-01-27 至 1997-11-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/6244330
• 关键词: antihypercholesterolemic agent; blood disorder chemotherapy; blood lipoprotein; blood lipoprotein metabolism; clinical research; combination therapy; diet therapy; dietary lipid; human subject; human therapy evaluation; hyperlipidemia; kidney transplantation; longitudinal human study; metabolism disorder chemotherapy; nutrition related tag

The objective of this proposal is to evaluate the composition and metabolic turnover rates of the various plasma lipoproteins in patients before and 6 months following renal transplantation, followed by intervention with a low-fat/low cholesterol diet, alone or in combination with cholesterol lowering medication. All of the planned patients have been enrolled and the study is the followup phase.

本建议的目的是评估组成情况， 患者中各种血浆脂蛋白的代谢周转率 肾移植前和肾移植后6个月， 低脂/低胆固醇饮食干预，单独或联合 降低胆固醇的药物。 所有计划中的病人都有 入组，研究为随访期。